Clinical Trials on Benign Prostatic Hyperplasia (BPH) in Ireland
Total 15 results
-
Nymox CorporationCompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Benign Prostatic Hyperplasia (BPH) | Enlarged ProstateUnited States
-
Watson PharmaceuticalsCompletedBenign Prostatic Hyperplasia (BPH)United States
-
Olympus Corporation of the AmericasRecruitingBenign Prostatic Hyperplasia (BPH)United States, United Kingdom, Canada
-
Resurge Therapeutics Inc.RecruitingLower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)New Zealand, Australia
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
Watson PharmaceuticalsCompletedBenign Prostatic HyperplasiaUnited States
-
Watson PharmaceuticalsCompletedBenign Prostatic HyperplasiaUnited States
-
Threshold PharmaceuticalsTerminatedBenign Prostatic HyperplasiaUnited States
-
Warner ChilcottCompletedBenign Prostatic HyperplasiaUnited States
-
Rhode Island HospitalTerminatedLower Urinary Tract Symptoms | Benign Prostatic HypertrophyUnited States
-
ProVerum MedicalRecruitingBenign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract SymptomsUnited States, Canada, Ireland
-
AEterna ZentarisCompletedBenign Prostatic HypertrophyUnited States, Canada
-
Vantia LtdCompleted
-
GlaxoSmithKlineCompletedProstatic HyperplasiaUnited States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
-
Brigham and Women's HospitalCVS CaremarkCompletedDepression | Epilepsy | Cardiovascular Disease | Diabetes | Breast Cancer | Parkinson's Disease | Mental Health Disorder | Prostatic Hypertrophy, BenignUnited States